Advertisements

Cifloxacin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Cifloxacin

What is Cifloxacin?

Cifloxacin is a synthetic broad-spectrum antibiotic belonging to the fluoroquinolone class. It is primarily used to treat a variety of bacterial infections by interfering with the ability of bacteria to replicate and repair their DNA.

Mechanism of Action

Cifloxacin works by inhibiting specific bacterial enzymes known as DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for the bacterial DNA to unwind and duplicate. By blocking these processes, the medication prevents the bacteria from multiplying, effectively stopping the spread of the infection and allowing the body's immune system to eliminate the remaining pathogens.

Classification and Spectrum

As a second-generation fluoroquinolone, Cifloxacin is known for its efficacy against a wide range of bacteria. Its spectrum of activity includes:

  • Gram-negative bacteria: It is particularly potent against many organisms that cause urinary tract, respiratory, and gastrointestinal infections.
  • Gram-positive bacteria: It shows activity against certain strains, though it is often more noted for its Gram-negative coverage.

Common Applications

Because of its ability to reach high concentrations in various body tissues and fluids, Cifloxacin is utilized in clinical settings for several types of infections. These generally include:

  • Urinary tract infections (UTIs)
  • Lower respiratory tract infections
  • Skin and soft tissue infections
  • Bone and joint infections
  • Infectious diarrhea and certain intra-abdominal infections

Cifloxacin is only effective against infections caused by bacteria; it does not treat viral infections, such as the common cold or influenza.

Regulatory References

  1. MedlinePlus Ciprofloxacin Drug Information
Advertisements

What side effects are possible with Cifloxacin?

Possible side effects and safety information

The safety profile of Cifloxacin, a fluoroquinolone antibiotic, is formally documented by regulatory authorities, classifying potential adverse reactions by both frequency and the physiological systems affected.

Frequency-Classified Adverse Reactions

Classification Examples of Reactions
Common (Affects up to 1 in 10) Nausea, Diarrhoea
Uncommon (Affects up to 1 in 100) Headache, Dizziness, Sleep disorders, Rash, Abnormal liver function tests

Serious adverse reactions are explicitly highlighted in official labeling due to their clinical significance. These include severe Musculoskeletal disorders such as tendon rupture and tendinitis, which may have a rapid onset occurring within hours or days of starting treatment. Effects on the Nervous system may include peripheral neuropathy (nerve damage) and seizures.

Additional serious risks documented by government health authorities involve vascular disorders like aortic dissection and aortic aneurysm, as well as severe gastrointestinal disorders such as Clostridioides difficile-associated diarrhoea (CDAD).

Population-Specific and General Constraints

The official safety information specifies increased risks for certain populations. Older adults have a higher documented risk for serious musculoskeletal events like tendon rupture. Caution is also noted for patients with myasthenia gravis, as the medication may exacerbate muscle weakness.

General safety constraints include the potential for photosensitivity reactions (heightened skin reaction to sunlight) and the risk of crystalluria (crystals in the urine) if proper hydration is not maintained.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Presentations and Physiological Effects

The acute overdose of ciprofloxacin has been documented primarily in a few case reports, notably including a single oral ingestion of mathbf12 g. The reported acute manifestations center on the renal system, resulting in mathbfreversible renal toxicity and the presence of mathbftransient crystalluria (crystals in the urine). A case of chronic overdose reported erosion and mathbfulceration of the gastrointestinal mucosa. Although serious side effects such as seizures and central nervous system (CNS) disturbances are associated with ciprofloxacin use in general, these effects can be heightened in an overdose scenario.

Required Emergency Actions

If an acute overdose is suspected, treatment is mathbfsymptomatic and mathbfsupportive. The clinical priority is to maintain mathbfadequate hydration and mathbfclosely monitor the patient’s condition. To remove any unabsorbed drug from the stomach, the use of mathbfactivated charcoal or mathbfgastric lavage may be recommended. Official labeling notes that only a small amount of ciprofloxacin, specifically mathbf<10%, is removed by mathbfhemodialysis or mathbfperitoneal dialysis.

When to Seek Immediate Medical Attention

While the overdose section itself does not provide explicit instructions on when to seek help, urgent medical attention is required for any serious effects associated with ciprofloxacin, which may be exacerbated by overdose. This includes symptoms such as: sudden severe pain in the chest, stomach, or back (potential sign of aortic damage); signs of an allergic reaction (hives, swelling of the face or throat, difficulty breathing); or signs of mathbfperipheral neuropathy (numbness, tingling, or burning pain in the arms or legs).

Advertisements

Therapeutic Uses of Cifloxacin

What Cifloxacin Treats: Main Uses and Benefits

Cifloxacin is applied across therapeutic domains where additional symptomatic support is needed, particularly in bacterial infections causing noticeable discomfort. The medication is commonly used to help with conditions characterized by periods of heightened symptoms in the urinary tract, lower respiratory tract, skin, bone, joint, and abdomen.

It helps address symptom clusters that may become intense or disruptive, such as painful burning during urination, fever, severe diarrhea, and localized redness and swelling. It is often used during phases when symptoms become more noticeable to control these manifestations. This supportive relief contributes to improved day-to-day comfort and assists with maintaining functional stability during symptomatic periods.

The application is relevant for easing discomfort and symptoms related to inflammatory or irritative states. This use is relevant in contexts marked by increased discomfort or tension, supporting the patient during difficult episodes by easing distress. Cifloxacin is generally applied in addressing symptom clusters related to bacterial causes.


Quick Fact: Relief for Localized Discomfort

Cifloxacin may assist with symptoms related to inflammatory or irritative states, such as pain and swelling, in specific areas like the skin or joints.

Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Cifloxacin — Official Regulatory Information

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed (as stated in label) Adults (18 years and older). Pediatric patients (1–17 years) are permitted only for specific, severe infections (e.g., Inhalational Anthrax, Complicated UTI/Pyelonephritis).
Populations for whom use is contraindicated Patients with known hypersensitivity to Ciprofloxacin or any fluoroquinolone; patients receiving concomitant administration of tizanidine.
Condition-specific eligibility rules Use must be avoided in patients with a history of myasthenia gravis. Requires caution in renal or hepatic impairment (dosage adjustment is required for renal insufficiency).
Pregnancy and lactation eligibility status (if explicitly documented) Use during pregnancy is generally reserved for compelling indications. Lactation is not recommended during treatment and for an additional 2 days after the last dose.
Eligibility-related restrictions Use requires caution in geriatric patients (due to tendon disorder risk) and those with QT interval prolongation or pre-existing aortic aneurysm/dissection.

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording
Eligibility severity classification Contraindicated (Absolute Exclusion); Avoid (Strong Exclusion); Restricted/Reserved (Conditional Use); Not Recommended (Conditional Exclusion); Caution (Conditional Use/Monitoring)
Regulatory basis FDA Prescribing Information, EMA Summary of Product Characteristics

Connection to the Overall Eligibility Profile

Official regulatory documents establish who can and cannot use Ciprofloxacin through absolute contraindications and strict conditional use criteria. These rules exclude patients with hypersensitivity or those taking tizanidine and mandate extreme caution for those with compromised organ function (renal/hepatic), pre-existing neuromuscular conditions, or specific cardiac and vascular risks. Pediatric use is severely limited, reserved for life-threatening infections where the regulatory benefit outweighs the risks.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cifloxacin’s interaction profile is strictly defined by regulatory documents, involving both pharmacokinetic and pharmacodynamic mechanisms. The co-administration of Cifloxacin with Tizanidine is formally contraindicated due to the severe increase in Tizanidine plasma concentration.

Pharmacokinetic and Absorption Interactions

Cifloxacin is documented as an inhibitor of CYP1A2 metabolism, leading to elevated concentrations of co-administered medicines that are metabolized by this pathway, such as Theophylline and Ropinirole. Additionally, co-administration with Probenecid interferes with the renal clearance of Cifloxacin itself, resulting in a documented 50% increase in its systemic exposure.

Multivalent Cation-Containing Products, including antacids, Sucralfate, and supplements with Iron or Zinc, cause a significant reduction in Cifloxacin absorption via chelation. To prevent this reduction in systemic exposure, Cifloxacin must be administered at least 2 hours before or 6 hours after these preparations. Concurrent use with dairy products or calcium-fortified juices taken alone should also be avoided for the same reason.

Pharmacodynamic and Additive Risks

An additive risk is documented when Cifloxacin is combined with other medicines that prolong the QT interval, such as certain antiarrhythmics, due to the potential for increased ventricular arrhythmias. Co-administration with Warfarin is officially noted to enhance the anticoagulant effect, requiring monitoring.

Advertisements

Mechanism of Action

How Ciprofloxacin Works

Ciprofloxacin achieves its physiological effect through the precise interruption of core bacterial survival mechanisms, leading to rapid cell death. This action is defined by two primary domains.

Targeting Bacterial DNA Gyrase and Topoisomerase IV

This mechanism involves Ciprofloxacin acting as a selective inhibitor against two essential bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. By binding to and stabilizing the DNA-enzyme cleavage complex, the drug prevents the resealing of cut DNA strands. This molecular interference halts the physical processes of DNA uncoiling and chromosome separation necessary for bacterial life and reproduction.

Inducing Catastrophic Cell Lysis (Bactericidal Effect)

The drug's molecular action results in a fatal accumulation of un-repaired DNA double-strand breaks, which triggers the bacterial SOS response pathway. This severe physiological stress forces the cell into an irreversible self-destruction process, leading to rapid cell lysis (rupture and death). This mechanism produces a definitive bactericidal (bacteria-killing) physiological effect, which contributes to the functional destruction of susceptible organisms.

Advertisements

Dosage and Administration Information

How to Use Cifloxacin: Administration Guidelines

Cifloxacin is used according to established instructions which define its route, dose, frequency, and preparation.


Routes and Forms

Cifloxacin is used for systemic administration via oral (immediate-release or extended-release tablets, suspension) and intravenous (IV) routes. It is also available for topical administration (ophthalmic and otic drops) for localized use.

Standard Dosing and Frequency

Systemic administration typically follows a twice-daily (q12hr) schedule for immediate-release (IR) forms, with doses generally ranging from 250 mg to 750 mg orally or 200 mg to 400 mg intravenously per dose. Extended-release (XR) tablets are administered once daily (q24hr) for specific indications. Treatment duration is fixed and can range from 3 days up to several months.

Administration Route Frequency Pattern Standard Adult Dose Range (per dose)
Oral (IR/Suspension) Twice daily (q12hr) 250 mg to 750 mg
Oral (XR) Once daily (q24hr) 500 mg to 1000 mg
Intravenous (IV) Twice or three times daily 200 mg to 400 mg

Administration Conditions and Adjustments

Cifloxacin may be taken with or without food. However, it must not be taken alone with dairy products (e.g., milk, yogurt) or calcium-fortified juices, as this reduces absorption. Patients with renal impairment (reduced kidney function) require a dose reduction or interval prolongation to prevent drug accumulation. Extended-release tablets must be swallowed whole and IV infusions must be administered slowly over 60 minutes.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Cifloxacin

This section provides an overview of the clinical research that has examined Cifloxacin, describing the types of studies conducted and the areas where research is still developing, without offering clinical guidance or recommendations.


Evidence for Use in Urinary Tract and Respiratory Infections

Researchers conducted short-term randomized controlled trials (RCTs) and systematic reviews to study Cifloxacin for conditions such as various types of urinary tract infections (UTIs) and lower respiratory tract infections. These studies were used in research exploring how symptoms change over time in adult populations, and in some cases, pediatric patients with complicated infections.

In these trials, studies monitored two main outcomes: Microbiological Eradication (clearance of the target bacteria) and Clinical Success, which measured outcomes related to physical discomfort and resolution of symptoms. Follow-up durations were limited, and available information for long-term outcomes characterizing the durability of clinical outcomes beyond the immediate post-treatment period is scarce.


Evidence for Use in Specialized and Severe Infections

Research has also examined Cifloxacin for conditions such as Inhalational Anthrax and Plague. Due to the critical public health and ethical challenges involved, traditional, large-scale, controlled human trials were not feasible for efficacy studies in these conditions.

Instead, evidence was primarily generated through studies conducted in animal models, where researchers monitored outcomes related to survival. For human populations, research describes data from settings where the drug was studied for post-exposure prophylaxis (following potential exposure), with studies monitoring adherence and safety during the defined time intervals.


Research Gaps and Areas of Uncertainty

The research landscape contains clear areas of uncertainty documented by official sources. Evidence suggests increasing documentation of bacterial resistance in key bacteria, which makes past efficacy results less predictive for current clinical practice. Furthermore, long-term effects are not fully established for many indications, as follow-up durations were limited in many pivotal trials. Data for certain groups, such as those with concurrent medication use, were often derived from studies with modest sample sizes or as part of a subgroup analysis, meaning certainty remains low compared to the core adult indications.

Key Studies & References

  1. Ciprofloxacin - StatPearls (Overview of Indications, Mechanisms, and Clinical Use)
  2. Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database (Post-marketing data on long-term effects)
  3. [Efficacy and safety of ciprofloxacin treatment in urinary tract infections (UTIs) in adults: a systematic review with meta-analysis]
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Cifloxacin (FAQ)


Q: Is Cifloxacin the same type of antibiotic as penicillin?

No, Cifloxacin (Ciprofloxacin) is classified as a synthetic antimicrobial agent belonging to the fluoroquinolone class. According to official product information, this is a distinct pharmacological group that is separate from penicillin and its related derivatives.


Q: What is the main infection Cifloxacin is prescribed for?

Regulatory documents indicate Cifloxacin is used for treating a variety of infections caused by susceptible bacteria. These include various types of urinary tract infections, lower respiratory tract infections, and infections of the skin and bone. The specific infections treated are based on regulatory indications and the organism’s susceptibility.


Q: What is the general classification of Cifloxacin?

Cifloxacin is classified as a fluoroquinolone antibiotic. This type of medicine is a synthetic compound that acts to eliminate bacteria. It belongs to the broader quinolone pharmacological group, as described in official product information.


Q: Can Cifloxacin affect blood sugar levels?

Yes, official safety information documents the risk of disturbances in blood glucose levels. These disturbances can include the potential for both high blood sugar (hyperglycemia) and low blood sugar (hypoglycemia). The potential need for monitoring blood glucose levels is noted in official documentation for some populations.


Q: What happens if I miss a scheduled dose of Cifloxacin?

Official patient guidance provides specific, non-directive procedures for handling a missed dose, which depend on the time remaining until the next scheduled dose. Patients are generally advised not to double the dose.


Q: What happens to Cifloxacin inside the body after it is absorbed?

After absorption, the body processes Cifloxacin into several compounds, which are generally described as having less antimicrobial activity than the active drug itself. According to official pharmacokinetic information, the drug is then primarily eliminated from the body through the urine.


Q: How long does Cifloxacin stay in the body after the last dose?

For individuals with normal kidney function, the official information indicates the drug has a serum elimination half-life of approximately 4 hours. This time frame describes how long it takes for half of the drug's concentration to be eliminated from the bloodstream.


Q: Can Cifloxacin change the taste sensation or cause a metallic taste?

Official documentation of adverse reactions includes reports of changes to taste sensation or a complete loss of taste. This is noted as a possible nervous system side effect of the medicine.


Q: Is there a generic version of Cifloxacin available?

Yes, regulatory bodies, such as the FDA, have approved generic versions of Ciprofloxacin in various forms, including tablets and oral suspensions. Ciprofloxacin is the active ingredient in Cifloxacin.


Q: Does research show Cifloxacin is effective against drug-resistant bacteria?

Regulatory labels describe the drug as effective against bacteria identified as susceptible in laboratory tests. However, official research documents also note increasing evidence of bacterial resistance in key organisms. The documentation of bacterial resistance remains a consideration for its use.


Q: Is Cifloxacin ever used for prophylaxis (preventing infection)?

Yes, regulatory documents indicate Cifloxacin is officially approved for prophylaxis (preventive use) in specific critical situations. These include prevention following exposure to conditions such as plague and inhalational anthrax (post-exposure).


Q: Does Cifloxacin interact with caffeine or energy drinks?

Official drug interaction information notes that Cifloxacin can inhibit the body’s clearance of caffeine and related compounds. This effect may result in the amount of caffeine in the body remaining elevated for longer.


Q: Are there any known long-term side effects associated with Cifloxacin use?

Official safety warnings describe that certain serious side effects affecting the tendons, muscles, nerves, and central nervous system can be potentially disabling and long-lasting. These effects may sometimes persist for months or years after the medicine has been discontinued.


Q: Does Cifloxacin interact with any commonly used herbal products?

Official patient information describes that it is important to disclose all products being used, including herbal products and vitamins, due to the potential for interactions. This is a common requirement noted in product labeling.


Q: Is there an age limit for people who can use Cifloxacin?

The drug is officially indicated for use in adults (18 years and older). For those under 18 years old, use is significantly restricted and reserved for specific, severe infections, such as complicated urinary tract infections or conditions like inhalational anthrax.


Q: Is there any research on Cifloxacin's use in chronic infections?

Regulatory indications include the use of Cifloxacin for the treatment of Chronic Bacterial Prostatitis. This is a specific condition involving a long-term bacterial infection in the prostate gland.


Q: Are there any restrictions on driving or operating machinery while using Cifloxacin?

Official documents describe that because the drug is associated with nervous system effects such as dizziness and confusion, these side effects may affect the ability to perform tasks like driving or operating complex machinery.


Q: Can Cifloxacin cause joint or tendon pain?

Official documentation lists joint pain and joint swelling as possible adverse reactions. These effects are classified alongside the more serious, but rarer, risks of tendinitis and tendon rupture.


Q: Is it true that Cifloxacin can cause sun sensitivity?

Yes, official safety information includes specific warnings regarding photosensitivity reactions. This means the skin may become highly reactive to sunlight, and official information notes this as a risk.


Q: Does Cifloxacin interact with common pain relievers like ibuprofen?

Official drug interaction documents warn that the use of Cifloxacin along with non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may be associated with an increased potential for central nervous system stimulation and seizure risk.


Q: Is it important to finish the full course of Cifloxacin, even if I feel better?

Regulatory patient information often states that the medicine should be continued for the duration prescribed by the healthcare professional. This statement is generally included in patient information due to the risk of incomplete microbiological eradication and the potential for developing drug-resistant bacteria.


Q: Can Cifloxacin cause a severe skin rash?

Official safety information notes the rare but serious risk of severe hypersensitivity reactions. These can include potentially life-threatening skin conditions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).


Q: What should I do if I experience unexpected side effects while on Cifloxacin?

Official safety documents describe that certain serious or severe side effects require immediate medical attention. Guidance on steps like drug discontinuation or contacting a healthcare provider is included in official patient information.


Q: Why is the drug Cifloxacin often used for urinary tract infections (UTIs)?

Cifloxacin is officially indicated for the treatment of various urinary tract infections. This is because clinical studies submitted to regulatory bodies demonstrated that the drug is effective against common bacteria that cause UTIs, such as E. coli.


Q: What conditions make someone ineligible to use Cifloxacin?

Absolute exclusions, known as contraindications, include a known hypersensitivity to Ciprofloxacin or any fluoroquinolone, and using it simultaneously with the drug tizanidine. Other conditions, such as certain cardiac or vascular risks, require extreme caution or restricted use.

Advertisements

How should Cifloxacin be stored and disposed of?

Storage and Disposal of Ciprofloxacin

Ciprofloxacin tablets and the reconstituted oral suspension must be stored at temperatures below 30 C (86 F), and the container should be kept tightly closed. The tablets must also be protected from intense ultraviolet light. The injection requires storage between 5 C and 25 C. All liquid forms, including the unmixed suspension, must be protected from freezing.

Stability and Child Safety

The reconstituted oral suspension is stable for only 14 days. All forms must be kept out of the reach of children.

Disposal Requirements

Unused or expired Ciprofloxacin should be discarded through an official drug take-back program. If unavailable, the medicine must be removed from its container, mixed with an undesirable substance (e.g., dirt), sealed in a bag, and placed in the household trash. Ciprofloxacin is not on the FDA's flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cifloxacin found in:

A-Z Index: